Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 23,136 | 25,663 | 21,936 | 14,811 | 14,260 |
| Operating Income | -23,136 | -25,663 | -21,936 | -14,811 | -14,260 |
| Interest Expense | 4,154 | 1,929 | 1,930 | 1,929 | 3,308 |
| Other Income | 646 | 489 | 520 | 688 | 3,438 |
| Pre-tax Income | -26,644 | -27,103 | -23,346 | -16,052 | -14,130 |
| Income Tax | -4,343 | -5,101 | -3,765 | -2,607 | -2,852 |
| Net Income Continuous | -22,301 | -22,002 | -19,581 | -13,445 | -11,278 |
| Net Income | $-22,301 | $-22,002 | $-19,581 | $-13,445 | $-11,278 |
| EPS Basic Total Ops | -0.38 | -0.38 | -0.33 | -0.23 | -0.22 |
| EPS Basic Continuous Ops | -0.38 | -0.38 | -0.33 | -0.23 | -0.21 |
| EPS Diluted Total Ops | -0.38 | -0.38 | -0.33 | -0.23 | -0.14 |
| EPS Diluted Continuous Ops | -0.38 | -0.38 | -0.33 | -0.23 | -0.09 |
| EBITDA(a) | $-22,935 | $-25,466 | $-22,049 | $-14,281 | $-13,867 |